
Cure51 – Ethical Principles in TechBio: Balancing Innovation with Responsibility
Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio The fusion of technology, data, and life sciences—known…
Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio The fusion of technology, data, and life sciences—known…
Cure51 and Worldwide Innovative Network (WIN), in personalized cancer medicine consortium have joined forces to bring cancer research to a…
AmazingContent, a leading expert in executive influence and AI-driven communication strategies. A pioneer in Leader Advocacy in France, AmazingContent offers…
Interview with Nicolas Wolikow and Simon Istolainen, Co-founders of Cure51 Nicolas Wolikow and Simon Istolainen are the co-founders of Cure51 and repeat entrepreneurs…
Welcomes Tennis Stars Daniil Medvedev and Alexander Zverev as Ambassadors Fungiball, the revolutionary fantasy tennis platform, has secured €2.2 million…
The six-month, equity-free programme is now open for applications until 8 December 2024. Social Tides has launched its second Grow…
Nicolas Wolikow and Simon Istolainen share their thoughts on how AI, wearables, and blockchain innovations are transforming healthcare and shaping…
Nicolas Wolikow and Simon Istolainen share their thought about cancer treatment. Nicolas Wolikow and Simon Istolainen are the co-founders of Cure51 and repeat…
Unveiling Cure51’s Revolutionary Approach in Cancer Treatment with Techbio Innovations Cure51, a forward-thinking techbio firm, has recently garnered a substantial…